JILLIAN JOHNSON: Open Payments
NPI 1447739230 · ROYSTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,052 in 54 payments from 21 companies in 2025. Trend: 2023 $818 · 2024 $1,306 · 2025 $1,052
Food & beverage: $1,052
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $161 |
| Lilly USA, LLC | 6 | $96 |
| ABBVIE INC. | 4 | $88 |
| Novo Nordisk Inc | 4 | $70 |
| PFIZER INC. | 3 | $65 |
| Exact Sciences Corporation | 3 | $63 |
| Corcept Therapeutics | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
Products named: REXULTI, MOUNJARO, Korlym, Auvelity, Kerendia, LEQVIO, NURTEC ODT, VRAYLAR.
Industry payments across GA — which companies pay providers there.
